Targeted proteomics in late-onset neonatal sepsis: an exploratory analysis.
Clinical and in vitro analyses identified biologically relevant candidate biomarkers that may support future diagnostic and monitoring strategies for neonatal sepsis in preterm infants and identified proteins related to inflammatory signaling, growth, and metabolic pathways.